Salesforce for pharma, GxP-aware throughout.
A pre-built accelerator for HCP engagement or MLR review on Salesforce Life Sciences Cloud — designed by a team that understands validated systems, built to ship in months.
◷ Available from Q3 2026Available from Q3 2026. Talk to us about bringing the launch date forward against a specific engagement.
The pharma CRM landscape changed in 2025. Most consultancies can’t meet the moment.
The pharma industry’s CRM landscape changed in 2025 when Veeva’s OEM agreement with Salesforce expired and Salesforce’s own Life Sciences Cloud went GA. Pharma affiliates and global commercial operations are re-evaluating, and most consultancies in the conversation are either generic Salesforce shops without GxP fluency, or Veeva-only specialists without a Salesforce alternative to recommend.
The Life Sciences Accelerator is built specifically for this moment — Salesforce Life Sciences Cloud delivered by a team that understands validated systems, MLR review, and HCP engagement workflows.
- A production deployment of Salesforce Life Sciences Cloud for the agreed use case
- A validated-systems delivery approach aligned with GxP requirements
- HCP engagement or MLR review workflows tuned to pharma reality
- Integration design respecting clinical, regulatory, and commercial data boundaries
- Evaluation and audit-trail design appropriate for regulated decisioning
- Optional Managed Agentforce tail
From £150k, fixed price. 4-9 months. Principal-led with a validated-systems delivery lead.
- Irish-headquartered or Irish-affiliate pharma operations
- Global pharma commercial functions re-evaluating Veeva
- Medical device and diagnostics companies with regulated commercial interactions
- Biotech firms scaling commercial operations